pyrazolanthrone has been researched along with Cholangiocellular Carcinoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hong, HJ; Hwang, H; Kim, H; Lee, H | 1 |
Ai, X; Chen, X; Liang, H; Lin, Y; Lu, Y; Zhang, B | 1 |
2 other study(ies) available for pyrazolanthrone and Cholangiocellular Carcinoma
Article | Year |
---|---|
L1 Cell Adhesion Molecule Promotes Migration and Invasion via JNK Activation in Extrahepatic Cholangiocarcinoma Cells with Activating
Topics: Anthracenes; Bile Duct Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cholangiocarcinoma; Enzyme Activation; Gene Knockdown Techniques; Humans; MAP Kinase Kinase 4; MAP Kinase Signaling System; Mutation; Neural Cell Adhesion Molecule L1; Protein Kinase Inhibitors; Proto-Oncogene Proteins p21(ras); RNA, Small Interfering | 2017 |
JNK inhibitor SP600125 enhances TGF-β-induced apoptosis of RBE human cholangiocarcinoma cells in a Smad-dependent manner.
Topics: Anthracenes; Apoptosis; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Caspases; Cell Line, Tumor; Cholangiocarcinoma; Enzyme Activation; Humans; JNK Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Signal Transduction; Smad Proteins; Transforming Growth Factor beta | 2013 |